Clinical Trials Browser

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT03723941 2024-08-01

ACACIA

Phase 3 Completed

40 enrolled

Endocrine

Adrenocortical Carcinoma

NCT02135419 2024-07-26

ANCHOR

Phase 3 Completed

4,446 enrolled 13 charts

GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

NCT02355379 2024-07-08

ADAGE

Phase 3 Recruiting

774 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06313567 2024-07-08

Metronomic Capecitabine in Stage III Gastric Cancer

Phase 3 Recruiting

722 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02109146 2024-05-29

Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma

Phase 3 Completed

332 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT00093470 2024-03-20

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

Phase 3 Completed

144 enrolled 8 charts

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT03469674 2023-10-11

PORTEC-4a

Phase 3 Active not recruiting

550 enrolled

Gynecologic

Endometrial Neoplasms

NCT00548756 2023-06-07

Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy

Phase 3 Completed

152 enrolled

CNS

Brain Neoplasms

NCT00033293 2023-04-18

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

Phase 3 Completed

53 enrolled 14 charts

CNS

Neuroblastoma

NCT05524389 2022-11-23

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Phase 3 Not yet recruiting

624 enrolled

Gynecologic

Endometrial Neoplasms

NCT02063685 2022-06-21

Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

Phase 3 Completed

807 enrolled

Lymphoid

Lymphoma, Follicular

NCT00346164 2022-04-28

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Phase 3 Completed

588 enrolled 22 charts

Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00075829 2021-11-01

BMT CTN 0102

Phase 3 Completed

710 enrolled 19 charts

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00108745 2021-09-30

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Phase 3 Unknown

1,157 enrolled 15 charts

Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

NCT03199989 2020-03-06

EPAC1

Phase 3 Unknown

1,254 enrolled

Gastrointestinal

Colonic Neoplasms

NCT01039376 2019-07-30

PROLONG

Phase 3 Terminated

480 enrolled 30 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT00300586 2019-05-28

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Phase 3 Completed

842 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00870701 2018-08-22

Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma

Phase 3 Terminated

77 enrolled

Sarcoma

NCT00048997 2018-06-08

Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer

Phase 3 Completed

356 enrolled 15 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00921414 2018-04-27

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

Phase 3 Completed

299 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT03016000 2017-07-28

Thalidomide Maintenance Treatment in DLBCL

Phase 3 Unknown

226 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00759109 2017-04-07

Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)

Phase 3 Completed

150 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00537199 2016-05-13

OraTest in Combination With Visual Examination and Visual Examination Alone

Phase 3 Terminated

1 enrolled 2 charts

Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00411281 2015-09-30

Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder

Phase 3 Withdrawn

MyeloidOther hematologic neoplasm

Myeloproliferative Syndrome, Transient, Leukemia, Leukemia, Myeloid, Acute

Clinical Trials

ANVIL

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

AMBASSADOR

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

LAP100

Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

SABR-SYNC

COV-IMMUNO

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

REGAL

SABR-COMET 10

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

ACACIA

ANCHOR

ADAGE

Metronomic Capecitabine in Stage III Gastric Cancer

Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

PORTEC-4a

Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

BMT CTN 0102

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

EPAC1

PROLONG

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma

Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

Thalidomide Maintenance Treatment in DLBCL

Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)

OraTest in Combination With Visual Examination and Visual Examination Alone

Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder